Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort

Introduction: Genetic studies have identified associations of carnosinase 1 (CN1) polymorphisms with diabetic kidney disease (DKD). However, CN1 levels and activities have not been assessed as diagnostic or prognostic markers of DKD in cohorts of patients with type 2 diabetes (T2D).Methods: We estab...

Full description

Bibliographic Details
Main Authors: Jiedong Qiu, Benito A. Yard, Bernhard K. Krämer, Harry van Goor, Peter van Dijk, Aimo Kannt
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.899057/full
_version_ 1811325484650201088
author Jiedong Qiu
Jiedong Qiu
Benito A. Yard
Bernhard K. Krämer
Harry van Goor
Peter van Dijk
Peter van Dijk
Aimo Kannt
Aimo Kannt
author_facet Jiedong Qiu
Jiedong Qiu
Benito A. Yard
Bernhard K. Krämer
Harry van Goor
Peter van Dijk
Peter van Dijk
Aimo Kannt
Aimo Kannt
author_sort Jiedong Qiu
collection DOAJ
description Introduction: Genetic studies have identified associations of carnosinase 1 (CN1) polymorphisms with diabetic kidney disease (DKD). However, CN1 levels and activities have not been assessed as diagnostic or prognostic markers of DKD in cohorts of patients with type 2 diabetes (T2D).Methods: We established high-throughput, automated CN1 activity and concentration assays using robotic systems. Using these methods, we determined baseline serum CN1 levels and activity in a T2D cohort with 970 patients with no or only mild renal impairment. The patients were followed for a mean of 1.2 years. Baseline serum CN1 concentration and activity were assessed as predictors of renal function impairment and incident albuminuria during follow up.Results: CN1 concentration was significantly associated with age, gender and estimated glomerular filtration rate (eGFR) at baseline. CN1 activity was significantly associated with glycated hemoglobin A1c (HbA1c) and eGFR. Serum CN1 at baseline was associated with eGFR decline and predicted renal function impairment and incident albuminuria during the follow-up.Discussion: Baseline serum CN1 levels were associated with presence and progression of renal function decline in a cohort of T2D patients. Confirmation in larger cohorts with longer follow-up observation periods will be required to fully establish CN1 as a biomarker of DKD.
first_indexed 2024-04-13T14:33:58Z
format Article
id doaj.art-9ac196f3bfbe47e1aa2b1cb70ad4568f
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T14:33:58Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-9ac196f3bfbe47e1aa2b1cb70ad4568f2022-12-22T02:43:05ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-07-011310.3389/fphar.2022.899057899057Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes CohortJiedong Qiu0Jiedong Qiu1Benito A. Yard2Bernhard K. Krämer3Harry van Goor4Peter van Dijk5Peter van Dijk6Aimo Kannt7Aimo Kannt85th Medical Department, University Hospital Mannheim, Heidelberg University, Mannheim, GermanyDepartment of Pathology and Medical Biology, University Medical Centre Groningen and University of Groningen, Groningen, Netherlands5th Medical Department, University Hospital Mannheim, Heidelberg University, Mannheim, Germany5th Medical Department, University Hospital Mannheim, Heidelberg University, Mannheim, GermanyDepartment of Pathology and Medical Biology, University Medical Centre Groningen and University of Groningen, Groningen, NetherlandsDepartment of Endocrinology, University Medical Centre Groningen and University of Groningen, Groningen, NetherlandsIsala, Diabetes Centre, Zwolle, NetherlandsFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, GermanyInstitute of Experimental Pharmacology, Medical Faculty Mannheim, Heidelberg University, Mannheim, GermanyIntroduction: Genetic studies have identified associations of carnosinase 1 (CN1) polymorphisms with diabetic kidney disease (DKD). However, CN1 levels and activities have not been assessed as diagnostic or prognostic markers of DKD in cohorts of patients with type 2 diabetes (T2D).Methods: We established high-throughput, automated CN1 activity and concentration assays using robotic systems. Using these methods, we determined baseline serum CN1 levels and activity in a T2D cohort with 970 patients with no or only mild renal impairment. The patients were followed for a mean of 1.2 years. Baseline serum CN1 concentration and activity were assessed as predictors of renal function impairment and incident albuminuria during follow up.Results: CN1 concentration was significantly associated with age, gender and estimated glomerular filtration rate (eGFR) at baseline. CN1 activity was significantly associated with glycated hemoglobin A1c (HbA1c) and eGFR. Serum CN1 at baseline was associated with eGFR decline and predicted renal function impairment and incident albuminuria during the follow-up.Discussion: Baseline serum CN1 levels were associated with presence and progression of renal function decline in a cohort of T2D patients. Confirmation in larger cohorts with longer follow-up observation periods will be required to fully establish CN1 as a biomarker of DKD.https://www.frontiersin.org/articles/10.3389/fphar.2022.899057/fulldiabetic nephropathycarnosinehistidine-dipeptidasediabetic complicationscarnosinase
spellingShingle Jiedong Qiu
Jiedong Qiu
Benito A. Yard
Bernhard K. Krämer
Harry van Goor
Peter van Dijk
Peter van Dijk
Aimo Kannt
Aimo Kannt
Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort
Frontiers in Pharmacology
diabetic nephropathy
carnosine
histidine-dipeptidase
diabetic complications
carnosinase
title Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort
title_full Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort
title_fullStr Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort
title_full_unstemmed Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort
title_short Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort
title_sort association between serum carnosinase concentration and activity and renal function impairment in a type 2 diabetes cohort
topic diabetic nephropathy
carnosine
histidine-dipeptidase
diabetic complications
carnosinase
url https://www.frontiersin.org/articles/10.3389/fphar.2022.899057/full
work_keys_str_mv AT jiedongqiu associationbetweenserumcarnosinaseconcentrationandactivityandrenalfunctionimpairmentinatype2diabetescohort
AT jiedongqiu associationbetweenserumcarnosinaseconcentrationandactivityandrenalfunctionimpairmentinatype2diabetescohort
AT benitoayard associationbetweenserumcarnosinaseconcentrationandactivityandrenalfunctionimpairmentinatype2diabetescohort
AT bernhardkkramer associationbetweenserumcarnosinaseconcentrationandactivityandrenalfunctionimpairmentinatype2diabetescohort
AT harryvangoor associationbetweenserumcarnosinaseconcentrationandactivityandrenalfunctionimpairmentinatype2diabetescohort
AT petervandijk associationbetweenserumcarnosinaseconcentrationandactivityandrenalfunctionimpairmentinatype2diabetescohort
AT petervandijk associationbetweenserumcarnosinaseconcentrationandactivityandrenalfunctionimpairmentinatype2diabetescohort
AT aimokannt associationbetweenserumcarnosinaseconcentrationandactivityandrenalfunctionimpairmentinatype2diabetescohort
AT aimokannt associationbetweenserumcarnosinaseconcentrationandactivityandrenalfunctionimpairmentinatype2diabetescohort